# Pfizer, Inc. – FDA Inspection, Jun 7, 2017

Source: https://www.keypedia.com/records/fda_inspections/pfizer-inc/f6b7f6c9-8550-47e9-a7cd-ecc54ff22ae0
Source feed: FDA_Inspections

> FDA inspection 1013440 of Pfizer, Inc., June 07, 2017. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 25 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013440
- Company Name: Pfizer, Inc.
- Inspection Date: 2017-06-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1284680 - 2025-10-24
- [FDA Inspection 1256477 - 2024-12-13](https://www.keypedia.com/records/fda_inspections/pfizer-inc/d45be9cf-ef2e-4d2d-9638-08e91b31a22c)
- FDA Inspection 1249289 - 2024-08-30
- FDA Inspection 1230476 - 2024-07-19
- FDA Inspection 1204434 - 2023-04-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-janik/2803fa51-5259-4632-93ad-c6f038bd2fd4)
- Issuing Officer
- [Nealie C. Newberger](https://www.keypedia.com/people/nealie-c-newberger/4b7addde-1217-4495-bac2-2f7e3fe2e780)

Company: https://www.keypedia.com/companies/pfizer-inc/4b87fbf2-bec7-4fde-adf0-4207cd7d93ff

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c